Dr Reddys Laboratories Share Price Today - Live Blog for May 21, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.08% gain, with the share price now at ₹1,225.00. Notably, the stock's PE ratio stands at 18.0800, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd experienced a -0.19% dip in its share price and is currently trading at ₹1,224.00. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.25%, reaching the current market value of ₹1,226.25 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd experienced a -0.18% downturn in its share price, and it's currently trading at ₹1,223.55. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares experienced a -0.20% reduction, with the current market price at ₹1,224.60. Investors are carefully considering their positions and seeking insights into the stock's future performance.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,227.20. The stock is currently trading at a PE of 18.0800, while the industry PE is 34.0854, prompting investors to assess its value proposition.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.07% in its share price, and it currently trades at ₹1,227.45 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a notable 0.05% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,228.05. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,227.40. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Following a noteworthy 0.20% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,231.15. When it comes to valuation, this stock has a PE ratio of 18.0800, with the industry PE ratio at 34.0854.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.57%, with its current market value per share resting at ₹1,227.90. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd witnessed a -0.35% drop in its share price and is currently trading at ₹1,221.85. With the stock's PE at 18.0800 and the industry PE at 34.0854, investors are weighing their options.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.11% increase. Presently, it is actively trading at ₹1,226.25.

Dr Reddys Laboratories Ltd's share price has dropped by -0.12%, a development that warrants careful analysis. Presently trading at ₹1,226.75, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -0.37% dip in its share price and is currently trading at ₹1,228.95. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,233.80 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.41%, reaching a current market price of ₹1,233.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares saw a -0.05% decrease, reaching a current market price of ₹1,237.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.18% decrease in its share price, and it is currently trading at ₹1,237.65. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.15% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,237.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd stock price decreased by -0.37%, with the current market value at ₹1,237.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.34%, reaching the current market price of ₹1,241.85. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a -0.45% decrease in its share price, and it is currently trading at ₹1,237.95. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.0800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.41% drop, and it's now trading at ₹1,240.80 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a remarkable 0.19% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,248.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.0800, while the industry's PE ratio is 34.0854.

Dr Reddys Laboratories Ltd's stock has surged by 0.81%, and it is currently trading at ₹1,245.30. Additionally, the stock maintains a PE ratio of 18.0800, while the industry PE is 34.0854.